Case Report

Ischemic Colitis of the Transverse Colon Induced by 5-Fluorouracil, Leucovorin, and Irinotecan: A Case Report

Abstract

Gastrointestinal complications are common in chemotherapy patients. Although most patients’ abdominal symptoms can be due to mild chemotherapy adverse reactions, severe or life-threatening complications might occur. Typhlitis or neutropenic enterocolitis is a severe bowel wall inflammation in leukemia or solid tumor chemotherapy in neutropenic patients and may contribute to necrosis and colon perforation. Patients undergoing chemotherapy rarely experience colitis that has no standard typhlitis trait. This ischemic colitis-induced chemotherapy had conducted in patients receiving taxane-based agents. Our study presented ischemic colitis in patients receiving 5-fluorouracil, Leucovorin, and Irinotecan for sigmoid cancer that affected the transverse colon alone, unlikely for both typhlitis and chemotherapy-induced ischemic colitis. Given these findings; it is prominent to consider that life-threatening gastrointestinal complications may develop with these agents, and then surgical intervention is needed

[1] Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, et al. Colitis associated with docetaxel-based chemother- apy in patients with metastatic breast cancer. The Lancet. 2000; 355(9200):281-3. [DOI:10.1016/S0140-6736(99)06195-4][PMID]
[2] Li Z, Ibrahim NK, Wathen JK, Wang M, Mante Menchu RP, Valero V, et al. Colitis in patients with breast carcinoma treated with taxane- based chemotherapy. Cancer. 2004; 101(7):1508-13. [DOI:10.1002/ cncr.20546] [PMID]
[3] Xia R, Zhang X. Neutropenic enterocolitis: A clinico-pathological review. World Journal of Gastrointestinal Pathophysiology. 2019; 10(3):36-41. [DOI:10.4291//wjgp.v10.i3.36] [PMID] [PMCID]
[4] Gorschlüter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IG, et al. Neutropenic enterocolitis in adults: Systematic analysis of evidence quality. European Journal of Haematology. 2005; 75(1):1- 13. [DOI:10.1111/j.1600-0609.2005.00442.x] [PMID]
[5] Gomez L, Martino R, Rolston KV. Neutropenic enterocol- itis: Spectrum of the disease and comparison of definite and possible cases. Clinical Infectious Diseases. 1998; 27(4):695-9. [DOI:10.1086/514946] [PMID]
[6] Fisherman JS, Cowan KH, Noone M, Denicoff A, Berg S, Poplack D, et al. Phase I/II study of 72-hour infusional paclitaxel and dox- orubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. Journal of Clinical Oncology. 1996; 14(3):774-82. [DOI:10.1200/JCO.1996.14.3.774] [PMID]
[7] Amonkar SJ, Cain HJ, Hughes T, Hemming JD, Browell DA. Adjuvant 5-fluorouracil-induced colitis necessitating completion colectomy. Journal of Gastrointestinal Cancer. 2011; 42(4):275-7[DOI:10.1007/s12029-010-9241-1] [PMID] . [8] E-I, Kawai K, Ando S, Shimazui T, Akaza H. Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer. Japanese Journal of Clinical Oncology. 2006; 36(1):60-3.[DOI:10.1093/jjco/hyi219] [PMID]
Files
IssueVol 7 No 1 (2022): January-February QRcode
SectionCase Report(s)
DOI https://doi.org/10.18502/crcp.v7i1.9626
Keywords
Colitis Chemotherapy Ischemia Irinotecan 5- Fluorouracil
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Elyasinia F, Fakhar N, Eslamian R, Pirouz A, Sadeghian E. Ischemic Colitis of the Transverse Colon Induced by 5-Fluorouracil, Leucovorin, and Irinotecan: A Case Report. CRCP. 2022;7(1):6-8.